The prescription opioid epidemic: an update

References

• Rivat C, Ballantyne J. The dark side of opioids in pain management: basic science explains clinical observation. Pain Rep. 2016;1(2):e570.
   PubMedGoogle Scholar
• Poitras G. OxyContin, prescription opioid abuse and economic medicalization. Medicoleg Bioeth. 2012;2:31–43.
   Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths – United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382.
   PubMed Web of Science ®Google Scholar
• Report of the President’s Commission on Combating Drug Addiction and the Opioid Crisis. Available from: https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Final_Report_Draft_11-1-2017.pdf. Accessed November 1, 2017.
   Google Scholar
• Cohen MJ, Jangro WC. A clinical ethics approach to opioid treatment of chronic noncancer pain. AMA J Ethics. 2015;17(6):521–529.
   Google Scholar
• Novy DM, Ritter LM, Mcneill J. A primer of ethical issues involving opioid therapy for chronic nonmalignant pain in a multidisciplinary setting. Pain Med. 2009;10(2):356–363.
   Web of Science ®Google Scholar
• Poitras G, Meredith L. Ethical transparency and economic medicalization. J Business Ethics. 2009;86(3):313–325.
   Web of Science ®Google Scholar
• Borchers AT, Hagie F, Keen CL, Gershwin ME. The history and contemporary challenges of the US Food and Drug Administration. Clin Ther. 2007;29(1):1–16.
   PubMed Web of Science ®Google Scholar
• van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–227.
   PubMed Web of Science ®Google Scholar
• Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no. 294. Hyattsville, MD: National Center for Health Statistics. 2017.
   Google Scholar
• Centers for Disease Control (CDC). Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2016;66:697–704.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses – a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10–13.
   PubMedGoogle Scholar
• Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017;390(10093):437–439.
   PubMed Web of Science ®Google Scholar
• Los Angeles Times [webpage on the Internet]. OxyContin goes global – “We’re only just getting started” [updated December 18, 2016]. Available from http://www.latimes.com/projects/la-me-oxycontin-part3/. Accessed September 3, 2018.
   Google Scholar
• Humphreys K, Caulkins J, Felbab-Brown V. Opioids of the masses: stopping an American epidemic from going global. Foreign Affairs. 2018;97(3):118–129.
   Web of Science ®Google Scholar
• Häuser W, Schug S, Furlan AD. The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents. Pain Rep. 2017;2(3):e599:1–11.
   Google Scholar
• Government Accounting Office. OxyContin abuse and diversion and efforts to address the problem: highlights of a government report. J Pain Palliat Care Pharmacother. 2004;18(3):109–113.
   Google Scholar
• GAO. OxyContin Abuse and Diversion and Efforts to Address the Problem. Washington, DC: GAO-04-110; 2003.
   Google Scholar
• United States of America vs. The Purdue Fredrick Company Inc. et al (WD Va., May 10, 2007, Case 1:07CR00029): 2.
   Google Scholar
• Gluck AR, Hall A, Curfman G. Civil litigation and the opioid epidemic: the role of courts in a national health crisis. SSRN Electron J. 2018:1–30.
   Google Scholar
• Haffajee RL, Mello MM. Drug companies’ liability for the opioid epidemic. N Engl J Med. 2017;377(24):2301–2305.
   PubMed Web of Science ®Google Scholar
• Commonwealth of Kentucky et al v. Purdue Pharma, L.P. et al (ED Kentucky, June 5, 2015, Case No. 7:07-cv-00222).
   Google Scholar
• Rich BA, Webster LR. A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose. Pain Med. 2011;12(Suppl 2):S59–S65.
   Google Scholar
• Smith DE. Medicalizing the opioid epidemic in the U.S. in the era of health care reform. J Psychoactive Drugs. 2017;49(2):95–101.
   PubMed Web of Science ®Google Scholar
• Nye RA. The evolution of the concept of medicalization in the late twentieth century. J Hist Behav Sci. 2003;39(2):115–129.
   PubMed Web of Science ®Google Scholar
• Conrad P. The Medicalization of Society. Baltimore, MD: Johns Hopkins Press; 2007.
   Google Scholar
• Centers for Disease Control (CDC). CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1–49.
   Web of Science ®Google Scholar
• Food and Drug Administration (FDA). FDA opioids action plan. Available from: https://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm484714.htm. Accessed July 11, 2017.
   Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, McLean RM, Forciea MA. Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514–530.
   PubMed Web of Science ®Google Scholar
• House W. Epidemic: Responding to America’s Prescription Drug Abuse Crisis, Washington, DC; 2011. Available from: https://obamawhitehouse.archives.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf. Accessed March 31, 2018.
   Google Scholar
• Netherland J, Hansen HB. The war on drugs that wasn’t: wasted whiteness, “Dirty Doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664–686.
   PubMed Web of Science ®Google Scholar
• Moore LD, Elkavich A. Who’s using and who’s doing time: incarceration, the war on drugs, and public health. Am J Public Health. 2008;98(5):782–786.
   PubMed Web of Science ®Google Scholar
• Friedmann PD, Andrews CM, Humphreys K. How ACA repeal would worsen the opioid epidemic. N Engl J Med. 2017;376(10):e16.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391–394.
   PubMed Web of Science ®Google Scholar
• Wootton B. Social Science and Social Pathology. Seal VG, Chambers R, editors. New York: Macmillan; 1959:206.
   Google Scholar
• Weeks WB, Goertz CM. Ineffective policies to address the opioid epidemic. JAMA Psychiatry. 2017;74(9):974.
   Web of Science ®Google Scholar
• Glod SA. The other victims of the opioid epidemic. N Engl J Med. 2017;376(22):2101–2102.
   PubMed Web of Science ®Google Scholar
• Warner M, Chen L, Makuc D, Anderson R, Miniño A. Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief. 2011;81:1–8.
   PubMedGoogle Scholar
• Jonas AB, Young AM, Oser CB, Leukefeld CG, Havens JR. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74(10):1602–1609.
   PubMed Web of Science ®Google Scholar
• Jones JD, Vosburg SK, Manubay JM, Comer SD. Oxycodone abuse in New York City: characteristics of intravenous and intranasal users. Am J Addict. 2011;20(3):190–195.
   Web of Science ®Google Scholar
• Carise D, Dugosh KL, Mclellan AT, Camilleri A, Woody GE, Lynch KG. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 2007;164(11):1750–1756.
   PubMed Web of Science ®Google Scholar
• Levy MS. An exploratory study of OxyContin use among individuals with substance use disorders. J Psychoactive Drugs. 2007;39(3):271–276.
   PubMed Web of Science ®Google Scholar
• Sees KL, di Marino ME, Ruediger NK, Sweeney CT, Shiffman S. Non-medical use of OxyContin tablets in the United States. J Pain Palliat Care Pharmacother. 2005;19(2):13–23.
   PubMedGoogle Scholar
• Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821–826.
   PubMed Web of Science ®Google Scholar
• Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med Overseas Ed. 2016;374(2):154–163.
   PubMed Web of Science ®Google Scholar
• Yokell MA, Delgado MK, Zaller ND, Wang NE, Mcgowan SK, Green TC. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Intern Med. 2014;174(12):2034–2037.
   PubMed Web of Science ®Google Scholar
• Riley ED, Cohen J, Shumway M. Overdose fatality and surveillance as a method for understanding mortality trends in homeless populations. JAMA Intern Med. 2013;173(13):1264–1265.
   PubMedGoogle Scholar
• Ries R, Krupski A, West II, et al. Correlates of opioid use in adults with self-reported drug use recruited from public safety-net primary care clinics. J Addict Med. 2015;9(5):1–26.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Overdose deaths involving prescription opioids among Medicaid enrollees – Washington, 2004-2007. MMWR Morb Mortal Wkly Rep. 2009;58(42):1171–1175.
   PubMedGoogle Scholar
• Green TC, Gilbert M. Counterfeit medications and fentanyl. JAMA Intern Med. 2016;176(10):1555–1557.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017;177:101–103.
   PubMed Web of Science ®Google Scholar
• O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700–10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–1202.
   PubMed Web of Science ®Google Scholar
• West Virginia Department of Health and Human Resources. West Virginia Drug Overdose Deaths, Historical Overview 2001-2015; 2017:4.
   Google Scholar
• Wakeman SE. Another senseless death – the case for supervised injection facilities. N Engl J Med. 2017;376(11):1011–1013.
   Web of Science ®Google Scholar
• Wood E. Strategies for reducing opioid-overdose deaths – lessons from Canada. N Engl J Med. 2018;378(17):1565–1567.
   PubMed Web of Science ®Google Scholar
• BC Centre for Disease Control. The opioid overdose emergency; 2017. Available from: http://www.bccdc.ca/resource-gallery/Documents/opioid od emergency bw 20170606 - BW.pdf. Accessed March 8, 2018.
   Google Scholar
• Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017.
   Google Scholar